The UK Collaborative HIV Cohort Study.

Trial Profile

The UK Collaborative HIV Cohort Study.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 Feb 2017

At a glance

  • Drugs Darunavir (Primary) ; Tenofovir disoproxil fumarate (Primary) ; Antiretrovirals; Atazanavir; Lopinavir
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms UK CHIC
  • Most Recent Events

    • 20 Feb 2017 Results of subgroup analysis assessing kidney function in patients who switched from atazanavir or lopinavir to darunavir published in the AIDS.
    • 24 Jan 2017 Results (n=15983) assessing risk factors of developing severe renal tubulopathy in patients treated with tenofovir disoproxil fumarate, published in the Journal of Infection
    • 20 Sep 2013 Accrual to date is 95% according to United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top